Funding
IFC and EAF to buy $52.5M Zenex stake
By Abha Lohia · Editor ·
Zenex Animal Health: revenue and funding and every story →
Growth equityAhmedabad
- IFC and its Emerging Asia Fund proposed to buy up to $52.5 million of Zenex shares from Multiples Private Equity Fund III
- IFC itself would put in about $16 million and the Emerging Asia Fund about $36.5 million
- Zenex began after buying Zydus Animal Health and Investment, a Cadila Healthcare subsidiary, and runs a plant in Haridwar
What happened
- IFC, part of the World Bank Group, filed to buy a stake in Zenex in December 2021.
- The shares come from existing investor Multiples, so this is a secondary sale (existing holder sells).
- Emerging Asia Fund is backed by IFC, Korea Development Bank and Fiji National Provident Fund.
Terms in this story
- Private equity: Venture capital backs young companies that could grow very fast, taking small stakes and accepting that many will fail, while private equity backs mature companies, often with large or controlling stakes and steadier returns. In India both usually invest through SEBI-registered AIFs, with venture capital funds in Category I and most private equity in Category II.
Everything on Zenex Animal Health → · All startup news on 6 December 2021 →
Is this Zenex Animal Health? Get your “Featured on StopDown” badge →